ImmunityBio, Inc. (IBRX) Investors: May 26, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP
businesswire.com
⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in